In focus · trending topic

patch

21 stories · following the connections

Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®

By Nasdaq OMXJul 27, 2017, 8:12 PM UTC

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Contraceptive Patch, Twirla®

By Nasdaq OMXJun 27, 2017, 12:00 PM UTC

Agile Therapeutics Reports First Quarter 2017 Financial Results

By Nasdaq OMXMay 8, 2017, 8:11 PM UTC

Agile Therapeutics to Present Additional Phase 3 Data at the 2017 Annual Clinical and Scientific Meeting of the American Congress of Obstetricians and Gynecologists

By Nasdaq OMXMay 3, 2017, 8:15 PM UTC

Agile Therapeutics to Present at 29th Annual ROTH Conference

By Nasdaq OMXMar 1, 2017, 9:10 PM UTC

Agile Therapeutics to Present at the RBC Capital Markets 2017 Global Healthcare Conference

By Nasdaq OMXFeb 14, 2017, 9:00 PM UTC

Agile Therapeutics to Present at the 2017 BIO CEO & Investor Conference

By Nasdaq OMXFeb 2, 2017, 9:15 PM UTC

Painters District Council No. 30 to Award Two Grants to Local Community Organizations

By Nasdaq OMXJan 24, 2017, 3:00 PM UTC